All are true about 18 FDG Pet scanning except
**Core Concept**
18 FDG PET scanning is a diagnostic imaging technique that utilizes positron emission tomography (PET) to visualize glucose metabolism in the body. It involves the administration of a radiolabeled glucose analog, 18F-fluorodeoxyglucose (18F-FDG), which accumulates in cells with high metabolic activity, such as cancer cells.
**Why the Correct Answer is Right**
The correct answer will be a statement that is false regarding 18 FDG PET scanning. 18 FDG PET scanning is a useful diagnostic tool for various conditions, including cancer, infections, and neurodegenerative diseases. It is particularly useful for identifying areas of high metabolic activity, such as tumor growth. The high sensitivity and specificity of 18 FDG PET scanning make it a valuable tool in the diagnostic and therapeutic management of many diseases.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because 18 FDG PET scanning is indeed a useful tool for detecting and staging cancer, particularly in certain types of cancers such as lymphoma and melanoma.
**Option B:** This option is incorrect because 18 FDG PET scanning is not typically used for detecting and staging neurodegenerative diseases, although it can be used to detect areas of high metabolic activity in the brain.
**Option C:** This option is incorrect because 18 FDG PET scanning is not typically used for detecting and staging cardiovascular disease, although it can be used to detect areas of inflammation in the heart.
**Option D:** This option is incorrect because 18 FDG PET scanning is not typically used for detecting and staging psychiatric disorders, although it can be used to detect areas of high metabolic activity in the brain that may be associated with certain psychiatric conditions.
**Clinical Pearl / High-Yield Fact**
A key clinical application of 18 FDG PET scanning is in the detection and staging of cancer, particularly in patients with lymphoma or melanoma. It is also useful for identifying areas of high metabolic activity in the brain that may be associated with certain neurodegenerative diseases.
**Correct Answer: A.**